Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography

Table 1 Inclusion and exclusion criteria of the study

Inclusion criteria	Exclusion criteria
Female sex	Pregnancy
Age older than 21 years	Recurrent disease
Not pregnant	Previous mastectomy
Suspicious lesion of the breast (on palpation or mammography)	Fine needle aspiration within 1 week prior to scintimammography
Recommendation for excisional biopsy after mammography	Core biopsy during the previous 4 weeks
Informed consent of the patient	Previous chemotherapy
	Medically unstable patient (severe arrhythmia, heart failure or recent surgery)

ISSN: 1465-542X